Cancer Incidence and Mortality among Non-Hispanic Black Individuals, New York County (Manhattan), 2016-2020

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 1,302.0 500.0 487.7-512.5 628.0 588.4 567.4-610.0 674.0 451.4 435.8-467.4 467.2 176.2 169.0-183.6 215.2 217.5 204.4-231.3 252.0 155.5 146.8-164.6
Oral cavity and pharynx 26.6 10.2 8.5-12.2 18.2 16.7 13.4-20.7 8.4 5.8 4.1-8.0 7.6 2.9 2.0-4.0 4.2 4.2 2.6-6.5 3.4 2.1 1.2-3.5
Esophagus 10.0 3.7 2.7-4.9 5.2 4.8 3.1-7.1 4.8 3.1 2.0-4.7 7.8 2.9 2.1-4.0 3.8 3.8 2.2-6.0 4.0 2.5 1.5-3.9
Stomach 23.4 9.1 7.5-11.0 12.6 12.2 9.3-15.8 10.8 7.0 5.2-9.2 11.6 4.4 3.3-5.7 6.0 5.5 3.7-7.9 5.6 3.3 2.2-4.8
Colorectal 105.8 41.0 37.5-44.7 54.0 52.5 46.3-59.4 51.8 33.7 29.6-38.2 45.6 17.3 15.1-19.8 23.4 24.2 19.9-29.1 22.2 13.0 10.7-15.8
Colon excluding rectum 76.6 29.5 26.6-32.7 37.6 36.8 31.6-42.6 39.0 25.3 21.7-29.2 34.0 13.0 11.1-15.2 16.0 16.8 13.2-21.0 18.0 10.6 8.5-13.2
Rectum & rectosigmoid 29.2 11.5 9.7-13.6 16.4 15.8 12.5-19.7 12.8 8.4 6.4-10.9 11.6 4.3 3.3-5.7 7.4 7.4 5.1-10.3 4.2 2.4 1.5-3.8
Liver / intrahepatic bile duct 45.0 16.4 14.3-18.7 31.2 28.2 23.8-33.2 13.8 8.5 6.6-10.8 26.0 9.7 8.1-11.6 16.6 16.3 12.9-20.4 9.4 5.8 4.2-7.8
Pancreas 47.6 17.7 15.5-20.2 22.4 21.9 17.9-26.5 25.2 15.3 12.7-18.4 39.0 14.4 12.4-16.6 17.0 16.8 13.3-20.9 22.0 13.1 10.7-15.9
Larynx 10.0 3.6 2.7-4.8 7.6 7.0 4.9-9.8 2.4 1.5 0.8-2.7 4.0 1.4 0.8-2.2 2.8 2.5 1.4-4.3 1.2 0.7 0.2-1.6
Lung and bronchus 155.8 58.3 54.3-62.6 72.8 69.7 62.6-77.5 83.0 51.3 46.4-56.7 90.6 33.6 30.6-36.9 45.0 44.5 38.8-50.9 45.6 27.5 24.0-31.5
Melanoma of the skin 4.0 1.5 0.9-2.3 1.4 1.2 0.5-2.6 2.6 1.7 0.9-3.1 0.8 0.3 0.1-0.8 0.2 0.2 0.0-1.1 0.6 0.3 0.1-1.2
Female breast             196.6 137.9 129.1-147.1             44.4 28.5 24.7-32.7
Cervix uteri             15.4 11.3 8.8-14.2             6.0 4.0 2.7-5.9
Corpus uterus and NOS             59.8 38.4 34.1-43.2             16.0 9.8 7.8-12.3
Ovary             14.2 9.9 7.6-12.6             10.0 6.2 4.6-8.2
Prostate       218.2 196.1 184.3-208.4             36.6 39.4 33.8-45.7      
Testis       4.0 3.6 2.2-5.7             0.2 0.2 0.0-1.3      
Urinary bladder (incl. in situ) 35.2 13.5 11.6-15.7 22.0 22.6 18.5-27.4 13.2 8.3 6.4-10.7 10.8 4.0 3.0-5.3 6.4 7.1 4.8-10.0 4.4 2.4 1.5-3.8
Kidney and renal pelvis 47.6 18.2 15.9-20.8 28.4 25.4 21.3-30.1 19.2 12.9 10.3-15.8 7.0 2.7 1.9-3.8 2.6 2.6 1.4-4.5 4.4 2.7 1.7-4.3
Brain and other central nervous system 10.4 4.3 3.2-5.7 4.6 4.4 2.8-6.8 5.8 4.2 2.7-6.2 7.2 2.8 1.9-3.9 4.4 4.0 2.5-6.2 2.8 1.8 1.0-3.2
Thyroid 25.4 10.6 8.8-12.6 4.8 4.1 2.6-6.2 20.6 16.3 13.2-20.0 0.6 0.3 0.0-0.8 0.4 0.5 0.1-1.7 0.2 0.1 0.0-0.9
Hodgkin lymphoma 9.2 3.9 2.8-5.2 5.0 5.0 3.2-7.5 4.2 3.1 1.9-4.9 0.2 0.1 0.0-0.5 0.2 0.2 0.0-1.1 0.0 0.0 0.0-0.7
Non-Hodgkin lymphomas 48.2 19.4 17.0-22.1 25.2 24.5 20.3-29.3 23.0 15.8 13.0-19.2 11.0 4.4 3.3-5.8 6.2 6.6 4.4-9.4 4.8 3.0 1.9-4.5
Myeloma 37.0 14.3 12.3-16.6 17.0 16.4 13.0-20.5 20.0 12.8 10.3-15.7 11.4 4.3 3.2-5.6 4.4 4.4 2.7-6.8 7.0 4.3 3.0-6.1
Leukemias 26.4 10.7 8.9-12.8 13.0 12.9 9.9-16.6 13.4 9.2 7.0-11.9 13.4 5.3 4.1-6.8 5.8 6.1 4.1-8.9 7.6 5.0 3.5-7.1

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
  • NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.